Brandt B Jones

Title: Brandt B Jones: Innovator in Viral Therapeutics

Introduction

Brandt B Jones is a notable inventor based in Bountiful, UT (US). He has made significant contributions to the field of viral therapeutics, holding 2 patents that focus on the diagnosis and treatment of herpes simplex virus diseases.

Latest Patents

One of his latest patents is titled "Diagnosis and treatment of herpes simplex virus diseases." This invention maps a herpes simplex labialis (HSL) susceptibility gene associated with HSL to the q11 region of chromosome 21. It provides methods for screening susceptibility or resistance to herpes simplex virus, particularly herpes simplex labialis, and diagnosing herpetic diseases such as HSL. Another significant patent is "Oligonucleotide complexes for use as anti-viral therapeutics." The methods disclosed in this patent are useful for treating a wide variety of diseases. Specifically, they target a transcription-altering agent to a specific site in a viral genome to inactivate the virus. Additionally, the methods provide for a triplex-forming oligonucleotide capable of interacting with a target site in a viral genome to alter transcription. These methods may be employed against viral pathogens or agents of bioterrorism.

Career Highlights

Brandt has worked with esteemed institutions such as the University of Utah Research Foundation and Yale University. His work has significantly advanced the understanding and treatment of viral infections.

Collaborations

Some of his notable coworkers include John D Kriesel and Mark F Leppert. Their collaborative efforts have contributed to the development of innovative therapeutic methods.

Conclusion

Brandt B Jones is a distinguished inventor whose work in viral therapeutics has the potential to impact the treatment of viral diseases significantly. His patents reflect a commitment to advancing medical science and improving patient outcomes.